Corporate Presentation
| Date | Documents | PDF Download |
|---|---|---|
| June 8, 2026 | Karyopharm Endometrial Cancer Treatment Landscape and Commercial Opportunity | |
| June 2, 2026 | Karyopharm Phase 3 SENTRY Results & Myelofibrosis Commercial Opportunity | |
| May 18, 2026 | Karyopharm Corporate Presentation | |
| May 14, 2026 | Karyopharm 1Q26 Earnings Presentation |
Karyopharm Therapeutics Phase 3 SENTRY Topline Results Conference Call
